ABG Pro DDx
By GDA Software
ABG Pro DDx is a clinical calculator for arterial blood gas and osmolar gap interpretation, designed for medical students and professionals on iOS and Android.
The App DNA
What makes this app unique?
The app removes the cognitive friction of manual acid-base calculations by providing automated differential diagnoses, which saves time during clinical rotations.
For Nurses, physicians, and medical students requiring clinical calculation tools for blood gas and acid-base interpretation.
What does it look like?
Key features
Calculates and interprets arterial blood gas values and osmolar gaps, including triple acid-base disorders.
Provides differential diagnoses for identified acid-base and osmolar disorders.
Allows users to define normal pCO2 and bicarbonate ranges for personalized interpretation.
How much does it cost?
The app operates on an ad-supported model with no paid tiers or in-app purchases, limiting revenue potential.
Velocity
Maintenance developmentperformanceplatform expansionShow more...
The app maintains a maintenance-level cadence, with only one version released in the observed window. The latest release focuses exclusively on stability and performance improvements for iOS and Android. Development appears stable but limited to technical upkeep rather than new feature expansion. The current release frequency averages approximately one update every 55 days.
Who built it?
User Sentiment
What do users think recently?
How are ratings & reviews evolving?
Not enough recent reviews to extract reliable themes yet.
Read the full review analysisCompetition
Competitive landscape for ABG Pro DDx
How's the Medical market?
ABG Pro DDx occupies a niche in the Medical category as a free, specialized calculator. The lack of a paid tier or subscription model contrasts with category leaders that monetize via recurring professional access.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for ABG Pro DDx
Where is it heading?
The clinical decision support market is consolidating around subscription platforms that offer continuous guideline updates. ABG Pro DDx remains exposed: its maintenance-only cadence and lack of recurring revenue prevent it from competing with platforms that offer real-time clinical content updates.
- Maintenance-only release cadence limits the app's ability to respond to evolving clinical standards, which compounds churn pressure from more active competitors.
- The ad-supported model provides low-friction entry for students, but fails to capture the higher ARPU available from established medical professionals.
The SWOT
- Customizable interpretation ranges function as a B2B-style distribution barrier for clinical workflows.
- Localized clinical guidelines could expand the user base into international markets.
Next best moves
Pivot ad-inventory strategy by introducing a "Pro" remove-ads IAP because the current ad-supported model limits revenue per session → increase ARPU.
+ 1 more prioritized moveThe counter-intuitive read
The ad-supported model is a strategic liability, not a convenience…
Read the full takeBottom line
ABG Pro DDx retains a niche user base through specialized differential diagnosis logic, but the ad-supported model caps revenue potential. Transitioning to a freemium model would unlock higher lifetime value from the professional segment, which currently relies on the app for daily clinical workflows.
Unlock 1 critical friction, 1 market threat, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
- [1] App Store
Report last updated